1. Primary registry and trial identifying number
|
129 (100.0%)
|
7 (100.0%)
|
136 (100.0%)
|
2. Date of registration in primary registry
|
129 (100.0%)
|
7 (100.0%)
|
136 (100.0%)
|
3. Secondary identifying numbers
|
97 (75.2%)
|
6 (85.7%)
|
103 (75.7%)
|
4. Source(s) of monetary or material support
|
127 (98.4%)
|
7 (100.0%)
|
134 (98.5%)
|
5. Primary sponsor
|
129 (100.0%)
|
7 (100.0%)
|
136 (100.0%)
|
6. Secondary sponsor(s)
|
121 (93.8%)
|
5 (71.4%)
|
126 (92.6%)
|
7. Contact for public queries
|
128 (99.2%)
|
7 (100.0%)
|
135 (99.3%)
|
8. Contact for scientific queries
|
128 (99.2%)
|
7 (100.0%)
|
135 (99.3%)
|
9. Public title
|
129 (100.0%)
|
7 (100.0%)
|
136 (100.0%)
|
10. Scientific title
|
129 (100.0%)
|
7 (100.0%)
|
136 (100.0%)
|
11. Countries of recruitment
|
129 (100.0%)
|
7 (100.0%)
|
136 (100.0%)
|
12. Health condition(s) or problem(s) studied
|
129 (100.0%)
|
7 (100.0%)
|
136 (100.0%)
|
16. Date of first enrollment
|
129 (100.0%)
|
7 (100.0%)
|
136 (100.0%)
|
17. Target sample size
|
129 (100.0%)
|
7 (100.0%)
|
136 (100.0%)
|
18. Recruitment status
|
129 (100.0%)
|
7 (100.0%)
|
136 (100.0%)
|
22. Completion date
|
119 (92.2%)
|
6 (85.7%)
|
125 (91.9%)
|
24. Data sharing plan
|
122 (94.6%)
|
6 (85.7%)
|
128 (94.1%)
|
Total common items average report percentage (%)
|
97.2%
|
95.8%
|
97.1%
|